Community/Ambulatory Volume 20, Issue 7

Medication Safety Alert! July 2021

In this month's issue:

  • Screening for Dihydropyrimidine Dehydrogenase (DPD) Deficiency in Fluorouracil Patients: Why Not?
  • Sidebar: Why not screen for dihydropyrimidine dehydrogenase (DPD) deficiency in patients receiving fluorouracil or capecitabine? (Letter from the NCCN [National Comprehensive Cancer Network])
  • Patient administration errors with the use of alprostadil urethral inserts
  • Improved safety needed for pediatric pegfilgrastim use
Related
Submit a Cheers Nomination
Support ISMP
Report an Error

Access this Newsletter

Purchasing Options

Purchase access to this individual issue

Purchase a year's access to this monthly publication (12 issues)

Purchase a year's access to this monthly publication for users at a single site location.